1-9 of 9
Franck Nicolini, MD
Close
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation for Blast Crisis (BC) Chronic Myelogenous Leukemia (CML) In the Tyrosine Kinase Inhibitors (TKIs) Era. Analysis of Pre-Transplant Variables on Transplant Outcome. On Behalf of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire and the French Group of CML

Franck Nicolini, MD, PhD, Laurent Modolo, Stat, Nicole Raus, Data, Noel Milpied, MD, Gerard Socie, MD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, Nathalie Fegueux, MD, Herve Tilly, MD, Didier Blaise, MD, Pierre Bordigoni, MD, Karin Bilger, MD, Catherine Cordonnier, Jean-Hugues Dalle, MD, PhD, Thierry De Revel, MD, PhD, Eric Deconninck, MD, Bernard Rio, MD, Anne Sirvent, Norbert Ifrah, MD, Gaelle Guillerm, MD, Valerie Mialou, Agnes Buzyn, MD, PhD, Anne Huynh, MD, Jacques-Olivier Bay, MD, PhD, Stephane Morisset, Stat., Mauricette Michallet
Journal: Blood
Blood (2010) 116 (21): 2266.
https://doi.org/10.1182/blood.V116.21.2266.2266
Published: 2010
Journal Articles

Mutations of TET2 , IDH1 , IDH2 and ASXL1 In Chronic Myeloid Leukemia.

Catherine Roche-Lestienne, Marceau Alice, Elise Labis, Olivier Nibourel, Valérie Coiteux, Joelle Guilhot, Laurence Legros, MD, Franck Nicolini, MD, PhD, Philippe Rousselot, MD, PhD, Martine Gardembas, Nathalie Helevaut, Cécile Frimat, Francois Guilhot, Claude Preudhomme
Journal: Blood
Blood (2010) 116 (21): 3377.
https://doi.org/10.1182/blood.V116.21.3377.3377
Published: 2010
Journal Articles

Homo-Harringtonine (Omacetaxine mepesuccinate) Induces a Dramatic and Sustained Reduction of BCR-ABL T315I mutated Transcripts in Chronic Phase Chronic Myelogenous Leukemia Patients Resistant to Tyrosine Kinase Inhibitors.

Franck Nicolini, MD, PhD, Laurence Legros, MD, PhD, Lydia Roy, MD, PhD, Jean-Claude Chomel, MD, Kaddour Chabane, BSc, Sophie Ducastelle, MD, Selim Corm, MD, Mauricette Michallet, MD, PhD, Francois Guilhot, MD, Ali Turhan, MD, PhD, Sandrine Hayette, PhD
Journal: Blood
Blood (2008) 112 (11): 1103.
https://doi.org/10.1182/blood.V112.11.1103.1103
Published: 2008
Journal Articles

Expanding Nilotinib Access in Clinical Trials (ENACT) Study in Adult Patients (Pts) with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Blast Crisis (BC), Accelerated Phase (AP), or Chronic Phase (CP): Preliminary Safety Analysis.

Franck Nicolini, MD, Giuliana Alimena, MD, Haifa-Kathrin Al-Ali, MD, Andrey Zaritskey, Zhixiang Shen, MD, Saengsuree Jootar, MD, Graeme Smith, MD, Yanzhi Hsu, Maria Luisa Veronese, David A. Rizzieri
Journal: Blood
Blood (2007) 110 (11): 2960.
https://doi.org/10.1182/blood.V110.11.2960.2960
Published: 2007
Journal Articles

Properties of CD34 + CML Cells That Predict Clinical Response to Tyrosine Kinase Inhibitors.

Xiaoyan Jiang, MD, PhD, Donna Forrest, MD, Franck Nicolini, MD, PhD, Karen Lambie, Kyi Min Saw, Emily Pang, Ranko Vukovic, Clayton Smith, MD, Allen Eaves, MD, PhD, Connie Eaves, PhD
Journal: Blood
Blood (2007) 110 (11): 324.
https://doi.org/10.1182/blood.V110.11.324.324
Published: 2007
Journal Articles

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Catherine Roche-Lestienne, PhD, Laureline Deluche, MD, Selim Corm, MD, Isabelle Tigaud, MD, Sami Joha, PhD, Nathalie Philippe, PhD, Sandrine Geffroy, PhD, Jean-Luc Lai, PhD, Franck Nicolini, MD, PhD, Claude Preudhomme, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2786.
https://doi.org/10.1182/blood.V110.11.2786.2786
Published: 2007
Journal Articles

Randomized Comparison of Imatinib with Imatinib Combination Therapies in Newly Diagnosed Chronic Myelogenous Leukemia Patients in Chronic Phase: Design and First Interim Analysis of a Phase III Trial from the French CML Group.

Agnès Guerci, MD, Franck Nicolini, MD, Frederic Maloisel, MD, Selim Corm, MD, Laurence Legros, MD, Françoise Rigal-Huguet, MD, Philippe Rousselot, MD, Krimo Bouabdallah, MD, Martine Gardembas, MD, Anne Vekoff, MD, Jean-Jacques Kiladjian, MD, Martine Delain, MD, François-Xavier Mahon, MD, Claude Preudhomme, MD, Joelle Guilhot, BS, François Guilhot, MD
Journal: Blood
Blood (2005) 106 (11): 168.
https://doi.org/10.1182/blood.V106.11.168.168
Published: 2005
Journal Articles

Quantification of Imatinib in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry: Applications to Therapeutic Drug Monitoring of Patients with Chronic Myelogenous Leukemia.

Francois-Xavier Mahon, MD, PhD, Stéphane Picard, MD, Karine Titier, MD, Franck Nicolini, MD, PhD, Dominique Ducint, MD, Nicolas Moore, MD, PhD, Gerald Marit, MD, Patrice Berthaud, MD, Mathieu Molimard, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1995.
https://doi.org/10.1182/blood.V106.11.1995.1995
Published: 2005
Journal Articles

B-Cell Depletion and Prevention of Hemolysis in Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO Incompatibility.

Emmanuelle Tavernier, MD, Anne Thiebaut, MD, Franck Nicolini, MD, PhD, Quoc Hung Le, MD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Daniela Revesz, MD, Olivier Hecquet, MD, PhD, Philippe Dubost, Jean-Paul Bourgeot, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5151.
https://doi.org/10.1182/blood.V104.11.5151.5151
Published: 2004